{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:45:20Z","timestamp":1782395120681,"version":"3.54.5"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2023.1339263","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T07:56:02Z","timestamp":1701762962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Immunology of cachexia"],"prefix":"10.3389","volume":"14","author":[{"given":"Vijay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"John H.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2012.06.013","article-title":"HIV-associated wasting","volume":"24","author":"Keithley","year":"2013","journal-title":"J Assoc Nurses AIDS Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1427-z","article-title":"Inflammation and cachexia in chronic kidney disease","volume":"25","author":"Cheung","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3684-6","article-title":"Muscle wasting in chronic kidney disease","volume":"33","author":"Oliveira","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tem.2021.03.007","article-title":"Cancer-mediated muscle cachexia: etiology and clinical management","volume":"32","author":"Siff","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0251-4","article-title":"Understanding cachexia in the context of metastatic progression","volume":"20","author":"Biswas","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia \u2014 understanding the tumour macroenvironment and microenvironment to improve management","volume":"20","author":"Argil\u00e9s","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2023.04.018","article-title":"Immunoregulation in cancer-associated cachexia","author":"Wu","year":"2023","journal-title":"J Adv Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026945","article-title":"NLRP3 inflammasome activation in peripheral arterial disease","volume":"12","author":"Bartoli-Leonard","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2174\/1389201019666180808162011","article-title":"Role of NLRP-3 inflammasome in hypertension: A potential therapeutic target","volume":"19","author":"Pasqua","year":"2018","journal-title":"Curr Pharm Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension","volume":"115","author":"Krishnan","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1272\/jnms.77.97","article-title":"Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase-3","volume":"77","author":"Ando","year":"2010","journal-title":"J Nippon Med Sch"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3225","article-title":"Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer","volume":"48","author":"Han","year":"2016","journal-title":"Int J Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa473","article-title":"PKM2-dependent glycolysis promotes skeletal muscle cell pyroptosis by activating the NLRP3 inflammasome in dermatomyositis\/polymyositis","volume":"60","author":"Liu","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13280","DOI":"10.1038\/ncomms13280","article-title":"PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation","volume":"7","author":"Xie","year":"2016","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310923","article-title":"Necroptosis mediates muscle protein degradation in a cachexia model of weanling pig with lipopolysaccharide challenge","volume":"24","author":"Guo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-12-801430-1.00003-2","article-title":"Activation of the NLRP3 inflammasome by proteins that signal for necroptosis","volume":"545","author":"Kang","year":"2014","journal-title":"Methods Enzymol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1613305114","article-title":"Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner","volume":"114","author":"Conos","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: Molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/jca.62788","article-title":"Association between platelet count with 1-year survival in patients with cancer cachexia","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.014639","article-title":"High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients","volume":"94","author":"Molnar","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"107615","DOI":"10.1016\/j.celrep.2020.107615","article-title":"Platelets fuel the inflammasome activation of innate immune cells","volume":"31","author":"Rolfes","year":"2020","journal-title":"Cell Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14073","article-title":"NLRP3 inflammasome activation in platelets in response to sepsis","volume":"7","author":"Cornelius","year":"2019","journal-title":"Physiol Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830231023","article-title":"The G protein-coupled receptor BLR1 is involved in murine B cell differentiation and is also expressed in neuronal tissues","volume":"23","author":"Kaiser","year":"1993","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"Legler","year":"1998","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184400","article-title":"Cachexia index as a prognostic indicator in patients with gastric cancer: A retrospective study","volume":"14","author":"Gong","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.984459","article-title":"Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study","volume":"12","author":"Wan","year":"2022","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2534-3","article-title":"Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer","volume":"23","author":"Kimura","year":"2015","journal-title":"Support Care Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"100020","DOI":"10.1016\/j.jtocrr.2020.100020","article-title":"Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced NSCLC","volume":"1","author":"Miyawaki","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.lungcan.2020.03.003","article-title":"Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors","volume":"143","author":"Roch","year":"2020","journal-title":"Lung Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01375-0","article-title":"Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors","volume":"125","author":"Mu","year":"2021","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1038\/s41598-022-11736-1","article-title":"Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy","volume":"12","author":"Goh","year":"2022","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"ltab011","DOI":"10.1093\/immadv\/ltab011","article-title":"Type 2 immunity is maintained during cancer-associated adipose tissue wasting","volume":"1","author":"Lenehan","year":"2021","journal-title":"Immunother Adv"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12450","article-title":"Macrophages protect against loss of adipose tissue during cancer cachexia","volume":"10","author":"Erdem","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1339263\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T07:56:03Z","timestamp":1701762963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1339263\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2023.1339263"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1339263","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"article-number":"1339263"}}